Imapextide sodium

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 18:41:17 GMT 2025` Edited by `admin` on `Wed Apr 02 18:41:17 GMT 2025`
Protein Type	FUSION PROTEINS
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	E6329K2XFW
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Imapextide sodium

Common Name

English

9-29-Glucagon-like peptide I [9-[N-(17-carboxy-1-oxoheptadecyl)-L-aspartic acid],16-glutamic acid,19-valine,20-arginine,28-arginine] (human) fusion protein with 30-39-exendin-4 (human), sodium salt (1:6)

Preferred Name

English

Code System Code Type Description

FDA UNII

E6329K2XFW

Created by admin on Wed Apr 02 18:41:17 GMT 2025 , Edited by admin on Wed Apr 02 18:41:17 GMT 2025

PRIMARY

CAS

3004571-16-5

Created by admin on Wed Apr 02 18:41:17 GMT 2025 , Edited by admin on Wed Apr 02 18:41:17 GMT 2025

PRIMARY

Related Record Type Details


					E8L272T7FX

Imapextide

PARENT -> SALT/SOLVATE

Amount:

Related Record Type Details


					E8L272T7FX

Imapextide

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION	[1_1]				1,16-Dicarboxyhexadecaneaspartamide	4J7XH73P9G
MOIETY					Sodium cation	LYR4M0NH37

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL